Published June 1, 2007 | Version v1
Journal article

Postoperative Irradiation of Gynecologic Malignancies: Improving Treatment Delivery Using Aperture-Based Intensity-Modulated Radiotherapy

  • 1. Departement de physique, de genie physique et d'optique, Universite Laval, Quebec, QC (Canada) and Departement de radio-oncologie et Centre de recherche de l'Hotel-Dieu de Quebec, Centre Hospitalier Universitaire de Quebec, Hotel-Dieu de Quebec, Quebec, QC (Canada)
  • 2. Departement de radio-oncologie et Centre de recherche de l'Hotel-Dieu de Quebec, Centre Hospitalier Universitaire de Quebec, Hotel-Dieu de Quebec, Quebec, QC (Canada)
  • 3. Departement de physique, de genie physique et d'optique, Universite Laval, Quebec, QC (Canada)

Description

Purpose: To evaluate dosimetric and treatment delivery advantages of aperture-based intensity-modulated radiotherapy (AB-IMRT) for the treatment of patients receiving whole pelvic radiotherapy for gynecologic malignancies. Methods and Materials: Nineteen patients undergoing pelvic radiotherapy after resection of endometrial cancers were selected. A 45-Gy dose was prescribed to the target volume delineated on a planning CT scan. An in-house inverse planning system, Ballista, was used to develop a treatment plan using aperture-based multileaf collimator segments. This approach was compared with conventional four-field, enlarged four-field, and static beamlet-based IMRT (BB-IMRT) techniques in terms of target coverage, dose-volume histogram statistics for surrounding normal tissues, and numbers of segments and monitor units (MU). Results: Three quarters (76.4%) of the planning target volume received the prescription dose with conventional four-field plans. With adequate target coverage, the Ballista plans significantly reduced the volume of bowel and bladder irradiated at the prescribed dose (p < 0.001), whereas the two approaches provided equivalent results for the rectum (p 0.5). On the other hand, AB-IMRT and BB-IMRT plans showed only small differences in dose-volume histogram statistics of unknown clinical impact, whereas Ballista plan delivery required on average 73% and 59% fewer segments and MU, respectively. Conclusion: With respect to conventional techniques, AB-IMRT for the treatment of gynecologic malignancies provides dosimetric advantages similar to those with BB-IMRT but with clear treatment delivery improvements

Additional details

Identifiers

DOI
10.1016/j.ijrobp.2007.01.046;
PII
S0360-3016(07)00196-4;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
68
Journal Issue
2
Journal Page Range
p. 601-611
ISSN
0360-3016
CODEN
IOBPD3

INIS

Optional Information

Copyright
Copyright (c) 2007 Elsevier Science B.V., Amsterdam, Netherlands, All rights reserved.